Downloads
CS/SB 844 — Sickle Cell Disease Care Management and Treatment Continuing Education
by Appropriations Committee on Health and Human Services and Senator Jones
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Health Policy Committee (HP)
The bill requires that the standard continuing education course on prescribing controlled substances, which must be taken by any health care practitioner who is registered with the United States Drug Enforcement Agency to prescribe controlled substances, must include information regarding the treatment of pain for patients with sickle cell disease.
If approved by the Governor, or allowed to become law without the Governor's signature, these provisions take effect on July 1, 2026.
Vote: Senate 37-0; House 113-0